aTyr Pharma (LIFE) Trims Q3 Loss
Tweet
Share
E-mailGet Alerts LIFE Hot Sheet
Join SI Premium – FREE
aTyr Pharma (NASDAQ: LIFE) reported Q3 EPS of ($0.48), versus ($8.02) reported last year.
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Goldman Sachs Reiterates Conviction Buy Rating on Golar LNG Ltd. (GLNG)
- JPMorgan Reinstates Dauch Corporation (DCH) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
